The lack of serious laboratory abnormalities in patients on isotretinoin suggests that reduced monitoring may suffice.
Dermatology Times – Dermatology
The lack of serious laboratory abnormalities in patients on isotretinoin suggests that reduced monitoring may suffice.
Dermatology Times – Dermatology